Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Raised to $475 at Cowen

May 4, 2017 3:39 PM
Cowen raised its price target on Regeneron Pharma (NASDAQ: REGN) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles